No black box warning on record for Lurasidone Hydrochloride

As of the latest FDA labeling reviewed, Lurasidone Hydrochloride (LURASIDONE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lurasidone Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) ( 5.3 ). • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring ( 5.4 ). • Tardive Dyskinesia: Discontinue if clinically appropriate ( 5.5 ). • Metabo

No black box warning on record for Lurasidone Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) ( 5.3 ). • Neuroleptic Malignant Syndrome: Manage with immediate discontinuation and close monitoring ( 5.4 ). • Tardive Dyskinesia: Discontinue if clinically appropriate ( 5.5 ). • Metabo

Lurasidone Hydrochloride Black Box Warning

No black box warning on record for Lurasidone Hydrochloride

Other warnings & precautions

Lurasidone Hydrochloride Black Box Warning

No black box warning on record for Lurasidone Hydrochloride

Other warnings & precautions